prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, FOR OPFICIAL USE ONLY - PERSONAL DATA - PRIVI. Y. Specimen #: (Age: ) P Race: Physician (s) : SPECIMEN: A: RIGHT SENTINEL NODE #1 B: RIGHT BREAST SENTINEL NODE #2. C: RIGHT BREAST LUMPECTOMY. FINAL DIAGNOSIS: A. LYMPH NODE, RIGHT AXILLA SENTINEL #1, BIOPSY: - ONE LYMPH NODE POSITIVE FOR MICROMETASTASIS (A1, LARGEST FOCUS, 0.27. MM - measured microscopically) ; ISOLATED TUMOR CELLS ALSO PRESENT. IN EXTRACAPSULAR LYMPHATIC SPACES. - ONE LYMPH NODE POSITIVE FOR ISOLATED TUMOR CELLS (A2). - ONE LYMPH NODE NEGATIVE FOR TUMOR BY H&E LIGHT MICROSCOPY AND. CYTOKERATIN IMMUNOHISTOCHEMISTRY (A3). B. LYMPH NODE, RIGHT AXILLA SENTINEL #2, BIOPSY: ONE LYMPH NODE NEGATIVE FOR TUMOR BY H&E LIGHT MICROSCOPY AND. CYTOKERATIN IMMUNOHISTOCHEMISTRY; HOWEVER, ISOLATED TUMOR CELLS ARE. PRESENT IN EXTRACAPSULAR LYMPHATIC SPACES. C. BREAST, RIGHT, LUMPECTOMY: - WELL-DIFFERENTIATED (GRADE I/III) INFILTRATING MUCINOUS (COLLOID). CARCINOMA. NOTTINGHAM HISTOLOGIC SCORE: 4 OUT OF 9 (Tubule formation = 2;. Nuclear pleomorphism = 1; Mitotic activity = 1). TUMOR SIZE: 4.0 CM (measured grossly). TUMOR NECROSIS OR CALCIFICATIONS ABSENT. VENOUS/LYMPHATIC INVASION: FOCI HIGHLY SUSPICIOUS FOR LYMPHATIC. INVASION. MARGINS : POSITIVE. INFILTRATING CARCINOMA IS PRESENT AT THE INKED. BLUE (SUPERIOR, E.G., SLIDE C2). ORANGE (ANTERIOR, E.G.,. SLIDE C3) RED (MEDIAL, E.G., SLIDE C8), AND BLACK (DEEP,. E.G., SLIDE C11) TISSUE EDGES. IN SITU COMPONENT: FOCAL DUCTAL CARCINOMA IN SITU, LOW NUCLEAR. GRADE (DCIS, GRADE 1) i SOLID AND FOCAL CRIBRIFORM TYPES. LYMPH NODES ONE OUT OF FOUR SENTINEL LYMPH NODES POSITIVE FOR. MICROMETASTASIS (please see part "A" and "B"). ESTROGEN RECEPTORS : POSITIVE (>95%, please see report. PROGESTERONE RECEPTORS: POSITIVE (90%, please see report. /. HER2NEU by IHC: NEGATIVE (Score 1+, please see report. Specimen #: FINAL DIAGNOSIS (continued) : PATHOLOGIC STAGE: pT2N1mi (. - ADDITIONAL PATHOLOGIC FINDINGS: STROMAL SCLEROSIS AND FOCAL MICROCYST FORMATION. FOCAL PRIOR BIOPSY SITE CHANGES. CLINICAL DIAGNOSIS AND HISTORY: Right breast cancer -year-old female. PRE-OPERATIVE DIAGNOSIS: None provided. POST-OPERATIVE DIAGNOSIS: None provided. GROSS DESCRIPTION: A: Received fresh, labeled with the patient's name. nd. designated, "Right Breast Sentinel Node #1" consists of three pink-tan. lymph nodes measuring 0.3 cm, 0.8 x 0.5 x 0.4 cm, and 1.5 x 1.2 x 0.5 cm. in. greatest dimension. Sectioning the larger lymph node reveals pink-red. otherwise unremarkable parenchyma. The specimen is entirely submitted. as follows: A1 - one lymph node, bisected; A2- one lymph node; A3 - one. lymph node. A matched section of A2 is submitted in OCT for. protocol. Time in formalin: B: Received in formalin, labeled with the patient's name. and. designated, "Right Breast Sentinel Node #2" consists of a 0.4 x 0.3 x 0.3. cm tan lymph node. The lymph node is bisected and submitted in its. entirety. Time in formalin: C: Received fresh, labelled with the patient's name. and. designated, "Right Breast Lumpectomy" consists of an ovoid portion of. firm, yellow-tan breast tissue oriented with a short stitch-superior; and. long Ititch-lateral. The specimen measures 6.5 cm from superior to. inferior; 5.5 cm from medial to lateral and 2.0 cm from anterior to deep. The specimen is inked as follows: superior-blue; inferior-green;. medial-red; lateral-yellow; anterior-orange and deep-black. Serial. sections reveal a firm, gritty, pink-tan mass measuring 4.0 x 3.5 x 1.5. I. Specimen #. GROSS DESCRIPTION (continued) : cm. The mass show well defined borders along the superior portion of the. specimen with patchy, ill defined distribution throughout the remainder of. the specimen, involving approximately 75% of the cut surface. The mass. abuts the superior, anterior, deep, and medial margins. The surrounding. breast tissue is dense, pink and white fibrous tissue. No other mass. lesions are identified. Representative sections are sequentially. submitted from superior to inferior as follows: C1-C2- mass with. superior. margin; C3-C5- mass with additional margins; C6- - adjacent normal; C7- mass. with additional margins; C8 - mass with additional margins; C9- mass with. lateral margin; C10- mass with additional margins; C11- mass with. additional margins; C12- inferior margin. Matched sections of C3,C5,C7,. and C9-C11 are submitted in OCT and paraffin for. protocol. Time in formalin: I.

expanded version (tokens=1773) : 
 Histological classification: The breast pathology report indicates that the patient has LumA subtype of invasive mucinous (colloid) carcinoma. There is also a focal ductal carcinoma in situ (DCIS) component, low nuclear grade (grade 1), with solid and focal cribriform types.

Necrosis: There is no mention of tumor necrosis.

Tumor Infiltrating Lymphocytes: The report does not indicate any specific mention of tumor infiltrating lymphocytes.

Histological Grade: The diagnosis mentions that the well-differentiated (Grade I/III) invasive mucinous (colloid) carcinoma has a Nottingham histologic score of 4 out of 9. The tubule formation score is 2, nuclear pleomorphism score is 1, and the mitotic activity score is 1.

Nuclear Grade: The low nuclear grade (Grade 1) DCIS component is mentioned in the report.

Lymphovascular Invasion: Focal areas of lymphatic invasion are suspected.

Calcification: There is no mention of calcifications.

Receptor Status: The report indicates that the carcinoma is estrogen receptors positive (>95%), progesterone receptors positive (90%), and HER2/NEU negative (score 1+).

IHC and Ancillary Testing: The report does not mention any other ancillary testing results.

In summary, the breast pathology report confirms that the patient has a well-differentiated (Grade I/III) infiltrating mucinous (col

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1900) : 
 The breast pathology report of a patient shows LumA subtype of invasive mucinous (colloid) carcinoma. It has a focal Grade 1 DCIS component and is estrogen and progesterone receptors positive, while HER2/NEU negative. No calcification was detected but focal areas of lymphatic invasion are suspected. Overall, areas are well-differentiated with no tumor necrosis mentioned.

